Citius Oncology, Inc.
CTOR · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $27 | $289 | – |
| Short-Term Investments | $0 | $0 | $0 | – |
| Receivables | $0 | $0 | $0 | – |
| Inventory | $8,269 | $0 | $0 | – |
| Other Curr. Assets | $2,700 | $7,735 | $2,690 | – |
| Total Curr. Assets | $10,969 | $7,735 | $2,690 | – |
| Property Plant & Equip (Net) | $0 | $0 | $0 | – |
| Goodwill | $0 | $0 | $0 | – |
| Intangibles | $73,400 | $40,000 | $40,000 | – |
| Long-Term Investments | $0 | $0 | $0 | – |
| Tax Assets | $0 | $0 | $0 | – |
| Other NC Assets | $0 | $0 | $0 | – |
| Total NC Assets | $73,400 | $40,000 | $40,000 | – |
| Other Assets | $0 | $0 | $0 | – |
| Total Assets | $84,369 | $47,735 | $42,690 | – |
| Liabilities | – | – | – | – |
| Payables | $3,712 | $1,289 | $92 | – |
| Short-Term Debt | $0 | $0 | $0 | – |
| Tax Payable | $0 | $0 | $0 | – |
| Deferred Revenue | $0 | $0 | $0 | – |
| Other Curr. Liab. | $28,989 | $19,758 | $5,754 | – |
| Total Curr. Liab. | $32,700 | $21,047 | $5,847 | – |
| LT Debt | $3,800 | $0 | $0 | – |
| Deferred Rev, NC | $0 | $0 | $0 | – |
| Deferred Tax Liab, NC | $1,728 | $1,152 | $576 | – |
| Other NC Liab. | $0 | $0 | $0 | – |
| Total NC Liab. | $5,528 | $1,152 | $576 | – |
| Other Liabilities | $0 | $0 | $0 | – |
| Cap. Leases | $0 | $0 | $0 | – |
| Total Liabilities | $38,229 | $22,199 | $6,423 | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | – |
| Common Stock | $7 | $7 | $7 | – |
| Retained Earnings | -$39,279 | -$18,130 | -$5,433 | – |
| AOCI | $0 | $0 | $0 | – |
| Other Equity | $85,412 | $43,659 | $41,693 | – |
| Total Equity | $46,140 | $25,536 | $36,267 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | – |
| Total Liab. & Tot. Equity | $84,369 | $47,735 | $42,690 | – |
| Net Debt | $3,800 | -$27 | -$289 | $0 |